Finance

Lists
SAUHF:OTCMKTS
Straumann Holding AG
USD 103,50
+0,29%
(+0,30) 1D
9 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SAUHF...
Open
USD 105,36
High
USD 105,36
Low
USD 103,50
Mkt. cap
14,61 mjd
Avg. vol.
478,00
Volume
0,00
52-wk high
USD 135,00
52-wk low
USD 93,18
Beta
1,60
Shares outstanding
159,46 m
No. of employees
12 k
Open
USD 105,36
High
USD 105,36
Low
USD 103,50
Mkt. cap
14,61 mjd
Avg. vol.
478,00
Volume
0,00
52-wk high
USD 135,00
52-wk low
USD 93,18
Beta
1,60
Shares outstanding
159,46 m
No. of employees
12 k
News stories
From web sources and news partners
Profile
Straumann Group is a Swiss company based in Basel manufacturing dental implants and specialized in related technologies. The group researches, develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry. The Straumann Group also offers services to the dental profession worldwide, including training and education, which is provided in collaboration with the International Team for Implantology and the Instituto Latino Americano de Pesquisa e Ensino Odontológico. Its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. Wikipedia
About Straumann Holding AG
CEOGuillaume Daniellot | Guillaume Daniellot
Employees11,6 k
Founded1954
HeadquartersBasel, Basel City, Switserland
SectorMedical device
Website-
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
628,60 m
628,60 m
689,73 m
689,73 m
Cost of goods sold
201,43 m
201,43 m
203,84 m
203,84 m
Cost of revenue
201,43 m
201,43 m
203,84 m
203,84 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
280,83 m
280,83 m
316,62 m
316,62 m
Operating expense
277,79 m
277,79 m
312,52 m
312,52 m
Total operating expenses
479,22 m
479,22 m
516,36 m
516,36 m
Operating income
149,38 m
149,38 m
173,38 m
173,38 m
Other non operating income
-3,58 m
-3,58 m
-2,93 m
-2,93 m
EBT including unusual items
81,29 m
81,29 m
156,66 m
156,66 m
EBT excluding unusual items
136,50 m
136,50 m
154,39 m
154,39 m
Income tax expense
21,37 m
21,37 m
31,32 m
31,32 m
Effective tax rate
26,29%
26,29%
19,99%
19,99%
Other operating expenses
-3,04 m
-3,04 m
-4,10 m
-4,10 m
Net income
59,74 m
59,74 m
124,85 m
124,85 m
Net profit margin
9,50%
9,50%
18,10%
18,10%
Earnings per share
-
-
-
-
Interest and investment income
48,95 m
48,95 m
18,66 m
18,66 m
Interest expense
-38,43 m
-38,43 m
-31,47 m
-31,47 m
Net interest expenses
10,52 m
10,52 m
-12,81 m
-12,81 m
Depreciation and amortization charges
-
-
-
-
EBITDA
158,16 m
158,16 m
214,24 m
214,24 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme